<?xml version="1.0" encoding="UTF-8"?>
<p>COVID-19 is characterized by pneumonia and persons with underlying cardiovascular disease associated with hypertension, diabetes, coronary artery disease or cerebral vascular disease are at higher risk of developing the severest from of the disease and demonstrate the highest rate of mortality (
 <xref ref-type="fig" rid="fig2-0004563220921888">Figure 2</xref>). Cardiac complications include the development of incident heart failure, acute coronary syndrome (ACS) and arrhythmia, all of which are associated with elevation in cTn
 <sup>
  <xref rid="bibr12-0004563220921888" ref-type="bibr">12</xref>
 </sup> especially when using high-sensitivity immunoassays and confer poor prognosis. Elevations in cTn are common in those with acute infectious respiratory disease and increases correlate with the severity of infection.
 <sup>
  <xref rid="bibr13-0004563220921888" ref-type="bibr">13</xref>
 </sup>
</p>
